Ni Liu - Publications

The N6-methyladenosine Epitranscriptomic Landscape of Lung Adenocarcinoma.

Journal: Cancer discovery

Published: October 13, 2023

Lung Cancer Driven by BRAFG469V Mutation Is Targetable by EGFR Kinase Inhibitors.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: December 24, 2020

Organoid Cultures as Preclinical Models of Non-Small Cell Lung Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: May 05, 2019

Molecular heterogeneity of non-small cell lung carcinoma patient-derived xenografts closely reflect their primary tumors.

Journal: International journal of cancer

Published: May 15, 2016

Clinical Utility of Patient-Derived Xenografts to Determine Biomarkers of Prognosis and Map Resistance Pathways in EGFR-Mutant Lung Adenocarcinoma.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: July 01, 2015

Integrating RAS status into prognostic signatures for adenocarcinomas of the lung.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: January 23, 2015

Validation of a histology-independent prognostic gene signature for early-stage, non-small-cell lung cancer including stage IA patients.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: December 06, 2013

Association of the 15q25 and 5p15 lung cancer susceptibility regions with gene expression in lung tumor tissue.

Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Published: April 28, 2012